Clinical trial
Study of 111In-DAC as a Medical Imaging Agent for the Detection of Breast Cancer
NCT00040430 · Copharos, Industry · Unknown status
Key facts
| NCT number | NCT00040430 |
|---|---|
| Title | Study of 111In-DAC as a Medical Imaging Agent for the Detection of Breast Cancer |
| Lead sponsor | Copharos, Industry |
| Status | Unknown status |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Drug, Procedure |
| Interventions | 111In-DAC, Diagnostic |
| First posted | Jun 28, 2002 |
| Last update posted | Jun 24, 2005 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: